Saudi Pharmaceutical Industries & Medical Appliances Corp.

Saudi Pharmaceutical Industries & Medical Appliances Corp. (SPIMAC) is a leading pharmaceutical and medical device company based in Saudi Arabia. The company manufactures, markets, and distributes a wide range of pharmaceutical products, including generic drugs, over-the-counter medicines, and medical appliances. It also engages in the import and export of pharmaceutical products and raw materials. SPIMAC serves both the public and private healthcare sectors, with a focus on providing affordable and high-quality medications to the Saudi market.

The company generates revenue primarily through the sale of pharmaceutical products and medical appliances. Its business model involves manufacturing generic drugs under license from international partners, as well as developing its own branded generics. SPIMAC also distributes products from third-party manufacturers. Key revenue drivers include contracts with government hospitals and clinics, as well as sales through private pharmacies and wholesalers. The recent financials show strong revenue growth of 9.74% year-over-year and a significant earnings surge of 279.94%, driven by improved margins and operational efficiency.

SPIMAC operates in the healthcare sector, specifically in the drug manufacturing industry for specialty and generic products. The company is one of the established players in the Saudi pharmaceutical market, competing with both local and multinational companies. Its competitive positioning is supported by a diverse product portfolio, strong distribution network, and strategic partnerships with global pharmaceutical firms. The company's gross margin of 55.71% and operating margin of 24.35% indicate solid profitability relative to peers. However, its debt-to-equity ratio is relatively high, with debt of 1.27B SAR against cash of 149.65M SAR.

The company's primary customers are healthcare providers, including hospitals, clinics, and pharmacies across Saudi Arabia. It also serves government health agencies and private healthcare institutions. The main geographic market is the domestic Saudi market, with potential for regional expansion. SPIMAC's products target a broad patient base, from chronic disease management to acute care. The company's focus on generic drugs makes it a key supplier for cost-conscious healthcare systems, particularly in the public sector.

An auto-generated descriptive profile based on company data, for informational purposes only.